Showing results (561-570 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|November 13, 2019
Cytoreductive treatment strategies for de novo metastatic prostate cancerMartin J Connor, Taimur T Shah, Gail Horan, et al.Nature Reviews. Clinical Oncology|February 2, 2019
Regulatory T cells in cancer immunosuppression - implications for anticancer therapyYosuke Togashi, Kohei Shitara, Hiroyoshi NishikawaNature Reviews. Clinical Oncology|December 19, 2019
Engineering strategies to overcome the current roadblocks in CAR T cell therapySarwish Rafiq, Christopher S Hackett, Renier J BrentjensNature Reviews. Clinical Oncology|December 15, 2019
Towards personalized treatment for early stage HER2-positive breast cancerKristina Goutsouliak, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, et al.Nature Reviews. Clinical Oncology|February 14, 2018
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versaKabir A Khan, Robert S KerbelNature Reviews. Clinical Oncology|March 7, 2018
Targeting the PI3K pathway in cancer: are we making headway?Filip Janku, Timothy A Yap, Funda Meric-BernstamNature Reviews. Clinical Oncology|December 29, 2017
Perioperative events influence cancer recurrence risk after surgeryJonathan G Hiller, Nicholas J Perry, George Poulogiannis, et al.Nature Reviews. Clinical Oncology|November 11, 2018
Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learnedLisa M Lowenstein, Spyridon P Basourakos, Michelle D Williams, et al.Nature Reviews. Clinical Oncology|November 16, 2016
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapyLorenzo Galluzzi, José Manuel Bravo-San Pedro, Sandra Demaria, et al.Nature Reviews. Clinical Oncology|November 3, 2016
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.Pageof 97